A Novel Peptidoglycan Binding Protein Crucial for PBP1A-Mediated Cell Wall Biogenesis in Vibrio cholerae by Dörr, Tobias et al.
 
A Novel Peptidoglycan Binding Protein Crucial for PBP1A-Mediated
Cell Wall Biogenesis in Vibrio cholerae
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Dörr, Tobias, Hubert Lam, Laura Alvarez, Felipe Cava, Brigid M.
Davis, and Matthew K. Waldor. 2014. “A Novel Peptidoglycan
Binding Protein Crucial for PBP1A-Mediated Cell Wall
Biogenesis in Vibrio cholerae.” PLoS Genetics 10 (6): e1004433.
doi:10.1371/journal.pgen.1004433.
http://dx.doi.org/10.1371/journal.pgen.1004433.
Published Version doi:10.1371/journal.pgen.1004433
Accessed February 16, 2015 10:28:36 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:12406573
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAAA Novel Peptidoglycan Binding Protein Crucial for
PBP1A-Mediated Cell Wall Biogenesis in Vibrio cholerae
Tobias Do ¨rr
1,2, Hubert Lam
1¤, Laura Alvarez
3, Felipe Cava
3, Brigid M. Davis
1,2, Matthew K. Waldor
1,2*
1Division of Infectious Diseases, Brigham & Women’s Hospital and Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts,
United States of America, 2Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America, 3Laboratory for Molecular Infection Medicine Sweden,
Department of Molecular Biology, Umea ˚ University, Umea ˚, Sweden
Abstract
The bacterial cell wall, which is comprised of a mesh of polysaccharide strands crosslinked via peptide bridges
(peptidoglycan, PG), is critical for maintenance of cell shape and survival. PG assembly is mediated by a variety of Penicillin
Binding Proteins (PBP) whose fundamental activities have been characterized in great detail; however, there is limited
knowledge of the factors that modulate their activities in different environments or growth phases. In Vibrio cholerae, the
cause of cholera, PG synthesis during the transition into stationary phase is primarily mediated by the bifunctional enzyme
PBP1A. Here, we screened an ordered V. cholerae transposon library for mutants that are sensitive to growth inhibition by
non-canonical D-amino acids (DAA), which prevent growth and maintenance of cell shape in PBP1A-deficient V. cholerae.I n
addition to PBP1A and its lipoprotein activator LpoA, we found that CsiV, a small periplasmic protein with no previously
described function, is essential for growth in the presence of DAA. Deletion of csiV, like deletion of lpoA or the PBP1A–
encoding gene mrcA, causes cells to lose their rod shape in the presence of DAA or the beta-lactam antibiotic cefsulodin,
and all three mutations are synthetically lethal with deletion of mrcB, which encodes PBP1B, V. cholerae’s second key
bifunctional PBP. CsiV interacts with LpoA and PG but apparently not with PBP1A, supporting the hypothesis that CsiV
promotes LpoA’s role as an activator of PBP1A, and thereby modulates V. cholerae PG biogenesis. Finally, the requirement
for CsiV in PBP1A-mediated growth of V. cholerae can be overcome either by augmenting PG synthesis or by reducing PG
degradation, thereby highlighting the importance of balancing these two processes for bacterial survival.
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Introduction
The bacterial cell wall is a remarkably sturdy, web-like structure
composed mainly of peptidoglycan (PG), a polysaccharide mesh
whose approximately parallel strands are crosslinked via peptide
sidechains [1–3]. It forms a relatively thin layer between the inner
and outer membranes of gram-negative bacteria, and a thicker
layer in gram-positive bacteria, for which it is often the outermost
bacterial structure. PG serves as a bacterial exoskeleton and
promotes maintenance of the shape and size of bacterial cells [4–
6]. The presence of PG allows bacteria to remain viable in
environments where the osmolarity of the extracellular millieu is
markedly lower than intracellular turgor pressure. Owing to PG’s
importance for bacterial survival, PG synthesis pathways are the
target of some of our most commonly used antibiotics, including
the beta lactams, cephalosporins and glycopeptides [7].
Most analyses of gram-negative cell wall biogenesis have been
performed in Escherichia coli. In this model organism, the first
extracytoplasmic step of PG assembly is polymerization of
disaccharide-pentapeptide precursors ([N-acetylglucosamine – N-
acetylmuramic acid]- pentapeptide) into glycan strands (transgly-
cosylation (TG)) [8]. Subsequently, the peptide residues of these
new strands are crosslinked (transpeptidation (TP)) to the existing
PG, enabling expansion of the PG mesh. These TG and TP
reactions are mediated by inner membrane-bound Penicillin
Binding Proteins (PBPs) [9], of which two (PBP1A and PBP1B) are
bifunctional, i.e. are able to catalyze both, TG and TP reactions.
PBP1A and PBP1B are largely functionally redundant and
conditionally essential, i.e., in the absence of one, the other
becomes strictly required for growth [10,11].
Recently, it was discovered that in vivo, the PG synthetic
activities of E. coli PBP1A and PBP1B are dependent upon
cognate outer membrane lipoproteins (LpoA and LpoB, respec-
tively) [12,13]. Some analyses suggest that both Lpo proteins
activate the TP activity of their partners; however, it has also been
suggested that LpoB can promote glycan chain polymerization
PLOS Genetics | www.plosgenetics.org 1 June 2014 | Volume 10 | Issue 6 | e1004433[14]. In either case, the Lpo proteins are thought to play an
essential regulatory role in PG synthesis, rather than a catalytic
role. Despite the distinct localization patterns of PBP1s (inner
membrane) and Lpo proteins (outer membrane), the PBP1/Lpo
pairs were found to interact directly. It has been hypothesized that
the activator proteins permit detection of gaps in the PG mesh,
and thereby induce synthesis of new material where needed (i.e.
where the cell wall has thinned, allowing for interaction between
Lpos and cognate PBP1s) [8].
Enzymes that cleave PG also play an essential role in the
survival and growth of gram-negative bacteria, and they are
required for PG synthesis in vivo. Endopeptidases, which cleave
the peptide bridges that link parallel glycan strands and thereby
reverse the process of transpeptidation, are thought to create space
into which new glycan strands can be inserted [15–17]. In E. coli,
multiple conditionally essential enzymes mediate this process. One
of 3 murein hydrolases must be present in order for incorporation
of new material into the cell wall to occur, and cells lyse in the
absence of all three [17].
V. cholerae, the gram-negative causative agent of the diarrheal
disease cholera, contains a similar repertoire of PG synthetic
enzymes as E. coli, including homologues of the PBP activators
LpoA and LpoB [18]. As seen with the E. coli enzymes, V.
cholerae PBP1A and PBP1B and their lipoprotein activators are
conditionally essential. However, we have observed that V.
cholerae lacking PBP1A or LpoA are more sensitive to a variety
of stressors than are wt bacteria or those lacking PBP1B/LpoB,
suggesting that PBP1A plays the dominant role in V. cholerae PG
synthesis [18]. PBP1A-deficient cells appear to be particularly
impaired in stationary phase, during which they lose their typical
rod shape and adopt a spherical morphology. V. cholerae also
produces functionally redundant endopeptidases that are required
for cell elongation and survival, although their absence does not
result in bacterial lysis [16]. Thus, V. cholerae and E. coli appear
to rely on similar but not identical processes for cell wall synthesis,
expansion, and maintenance.
One notable difference between V. cholerae and E. coli PG
results from V. cholerae’s production of non-canonical D-amino
acids (DAA), i.e., DAA other than D-Ala and D-Glu, which are
typical components of PG peptide side chains [2,19]. As V.
cholerae enters stationary phase, its periplasmic amino acid
racemase BsrV enables it to produce additional DAA, predom-
inantly D-Met and D-Leu, which are incorporated into PG
[20,21]. Mutants unable to produce or incorporate non-canonical
DAA into PG are hypersensitive to osmotic stress, suggesting that
the strength of stationary phase PG is modulated by these DAA.
Interestingly, DAA likely contribute to the altered shape and
survival of stationary phase V. cholerae lacking PBP1A or LpoA,
as these mutants cease growth and assume a spherical shape in the
presence of ,1 mM concentrations of D-Met. In contrast, the
growth and morphology of wild type and PBP1B/LpoB-deficient
cells is unperturbed by exposure to DAA. However, the precise
role of DAA in stationary phase, and the means by which they
modulate V. cholerae PG, remain to be identified.
Here, with the aim of increasing our understanding of the
processes modulated by DAA, we screened an ordered transposon
library of V. cholerae for additional mutants that are sensitive to
growth inhibition by DAA. Besides the expected insertions in the
genes encoding PBP1A and LpoA, the screen was answered by an
insertion in a gene of unknown function (vc1887), which we have
subsequently renamed CsiV (for cell shape integrity Vibrio). A
mutant lacking CsiV shares numerous additional phenotypes with
mutants lacking PBP1A or LpoA, although the three mutants are
not identical in all assays. In particular, only the effect of csiV
disruption could be moderated by deletion of shyA, which encodes
an endopeptidase that hydrolyzes peptide crosslinks between PG
strands. Biochemical analyses revealed that CsiV interacts both
with PG and with LpoA. Collectively, our data suggests that
PBP1A-mediated PG synthesis in V. cholerae is largely dependent
upon the presence of CsiV, which likely modulates the activity of
the PBP1A activator LpoA.
Results
Identification of potential PBP1A pathway mutants by a
chemical synthetic lethal screen
We analyzed the growth of an arrayed V. cholerae transposon
library on agar containing 5 mM D-Methionine (D-Met) (Fig. 1A).
Of the 3,156 mutants in the library, only three were unable to
grow under these conditions: strains with transposon insertions in
mrcA (which encodes PBP1A), in lpoA (vc0581; which encodes a
putative PBP1A activator [18]), and in vc1887, whose putative
product is annotated as a hypothetical protein. In-frame deletions
of vc1887 and lpoA also prevented growth of V. cholerae in the
presence of D-Met, as reported for deletion of mrcA (Fig. 1B;
[19]). Furthermore, growth of each mutant could be restored by
ectopic expression of the deleted gene, thereby demonstrating that
the mutations do not have polar effects and that the observed
growth deficiency is due to the absence of the deleted genes
(Fig. 1B). Collectively, these results indicate that PBP1A, LpoA,
and VC1887 are all required for survival of V. cholerae in the
presence of DAA, and raise the possibility that VC1887, like
LpoA, makes a key contribution to PBP1A-mediated PG synthesis.
Based on our subsequent analyses of VC1887 (detailed below), we
have renamed VC1887 as CsiV (for cell-shape integrity in Vibrio).
The amino terminus of CsiV is predicted to encode a signal
sequence for export to the periplasm (Fig. 2A), and, consistent
with this prediction, a CsiV-mCherry-fusion (Fig. S1) was
targeted to the cell periphery, where it was diffusely distributed
(Fig. 2B). Based on a String Database search for CsiV
homologues, CsiV contains no additional domains with a known
function in any bacterial genome. CsiV is largely restricted
to Vibrionaceae and certain Alteromonadales (especially genus
Author Summary
Bacteria surround themselves with a mesh-like peptido-
glycan (PG) cell wall, which is essential for maintenance of
cell shape and survival. While the enzymes that catalyze
the assembly of the cell wall (aka penicillin-binding
proteins (PBPs)) have been extensively characterized, our
understanding of the factors that modulate the activities
of these enzymes is less developed. Here, using a genetic
screen, we identified a gene of unknown function that
plays a crucial role in PBP1A-mediated cell wall synthesis in
Vibrio cholerae, the bacterium causing cholera. V. cholerae
mutants lacking this gene, whose protein product was re-
named CsiV (for Cell shape integrity Vibrio), share many
phenotypes with PBP1A mutants, including becoming
spherical during stationary phase. We show that CsiV
interacts with LpoA, a lipoprotein activator of PBP1A, as
well as with PG. CsiV, LpoA, or PBP1A are all required for
survival of V. cholerae lacking PBP1B, and mutants lacking
any of these factors show marked changes in PG content
in stationary phase. Collectively, our data suggest that CsiV
acts through LpoA to promote PG biogenesis in V. cholerae
and other vibrio species as well as in the other genera
where this protein is found.
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homologues only present within the genus Vibrio (Fig. S2).
Structural prediction analysis (Phyre2; http://www.sbg.bio.ic.ac.
uk/phyre2/html/page.cgi?id=index) did not identify high confi-
dence structural homologues for any portion of the CsiV protein
sequence, and the majority of the protein was predicted to be
disordered. Thus, sequence analysis did not provide any clues
regarding CsiV’s function.
Figure 1. Identification and complementation of PBP1A pathway mutants using a chemical genetic screen. (A) For the screen, an
ordered V. cholerae transposon library was pintooled onto LB agar +/25 mM D-Met and scored for growth deficiency in the presence of D-Met. (B)
Growth of V. cholerae PBP1A pathway mutants containing either an empty vector (pHL) or a plasmid enabling inducible expression of the deleted
gene (pHLorf) on plates containing inducer and 5 mM D-Met confirms that their growth deficiencies on D-Met are due to deletion of the indicated
genes.
doi:10.1371/journal.pgen.1004433.g001
A PG-Binding Protein That Promotes Cell Wall Biogenesis in V. cholerae
PLOS Genetics | www.plosgenetics.org 3 June 2014 | Volume 10 | Issue 6 | e1004433Figure 2. CsiV is a periplasmic protein of unknown function. (A) Domain architecture of CsiV (VC1887). The signal sequence is predicted to be
cleaved off between A30 and R31. DUF2803 is not associated with any function. (B) Fluorescence microscopy analysis of V. cholerae producing
plasmid-encoded CsiV-mCherry, a functional fusion protein that localizes to the cell periphery. Scale bar=5 mm.
doi:10.1371/journal.pgen.1004433.g002
Figure 3. A csiV mutant phenocopies the growth deficiencies of mrcA and lpoA mutants. The minimum inhibitory concentration (MIC) of
(A) deoxycholate, (B) cefsulodin and (C) DAA are shown for wt V. cholerae and PBP1A pathway mutants. MIC data reflect values obtained with two
biological replicates done in technical quadruplicates for each strain. Absence of error reflects that the same values were obtained for all experiments
(D) Morphological changes induced by DAA. The indicated V. cholerae strains were grown in the absence of DAA until OD600,0.3 and then applied to
0.8% agarose pads containing 4 mM D-Met. Scale bar=5 mm.
doi:10.1371/journal.pgen.1004433.g003
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pathway mutants
Given the similar responses of the DcsiV, DmrcA, and DlpoA
mutants to D-Met, we tested whether the DcsiV strain shared
other characteristics with PBP1A pathway mutants, such as loss of
rod shape after exposure to DAA, as well as sensitivity to
detergents and beta-lactam antibiotics [19]. These analyses
revealed numerous attributes that are shared among all 3 strains.
The minimum inhibitory concentrations (MIC) of deoxycholate
and cefsulodin were dramatically reduced (.100 fold and ,10
fold, respectively) for all three strains compared with wild type V.
cholerae (Fig. 3A,B), and the MIC for DAA was reduced 5–10
fold (Fig. 3C). Furthermore, all three strains turned spherical in
the presence of D-Met (Fig. 3D), and the process of sphere
formation was comparable for the DcsiV, DmrcA, and DlpoA
strains (Fig. 3D). At first, small blebs were evident protruding
from the cylindrical portion of the cell (the site of cell elongation);
then, within the subsequent ,5–10 min, DAA induced a
catastrophic loss of cell shape. Thus, the three mutants appear
to display similar sensitivities to a range of stresses thought to
target the cell envelope. Finally, perhaps consistent with increased
susceptibility to cell envelope stresses, DcsiV was also similarly
defective in colonization of infant mice as the PBP1A pathway
mutants (Fig. S3).
Comparative analyses of PG from wt and DAA-
susceptible strains
Given PBP1A’s prominent role in PG synthesis, we also
compared PG content and composition for wt V. cholerae and
the three mutants. Based on the abundance of diaminopimelic
acid (a PG constituent) in cell wall material isolated from
exponential phase cultures, 50–90% of wild type PG (normalized
to OD600) could be recovered from all three mutants, suggesting
cells can compensate almost fully for the loss of the PBP1A
pathway and CsiV during exponential phase. In contrast, for
stationary phase cultures, PG recovery from both the DmrcA and
DcsiV mutants was ,90% less than from wild type V. cholerae
(Fig. 4A). The DlpoA mutant also contained markedly less PG
Figure 4. Muropeptide analysis of the csiV, mrcA and lpoA mutants. Cell wall content was estimated by colorimetric quantification of DAP in
PG extracted from (A) exponential phase or (B) stationary phase cultures. (C–F) UPLC analysis of the degree of crosslinking (C,D) and average chain
length (E, F) in cell wall extracted from exponential phase (C,E) and stationary phase (D,F) cultures. Data are averages of two (exponential phase) or
three (stationary phase) biological replicates, error bars indicate standard deviation. **=p,0.01 (t-test). S481T is a PBP1A transpeptidase mutant
expressed from its native chromosomal locus, where the S residue at position 481 (in the active site) is replaced by a T.
doi:10.1371/journal.pgen.1004433.g004
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DcsiV mutants. These results suggest that PBP1A is responsible for
a high proportion of V. cholerae PG synthesis during the
transition into or in stationary phase, and suggest that this
synthesis may be dependent upon CsiV.
To gain insight into the regulation of PBP1A’s transpeptidase
(TP) and transglycosylase (TG) activities and their connection to
CsiV, we also compared the degree of crosslinking and the length
of glycan chains in PG from the wt and mutant strains. For these
analyses, we included a mrcA mutant (S481T) predicted to
produce PBP1A that lacks TP activity, due to disruption of the
enzymatic active site. We found that crosslinking was slightly and
insignificantly reduced, relative to the wt strain, in exponential
phase-derived PG from all four mutants (DcsiV, DmrcA, DlpoA,
mrcAS481T)( Fig. 4C). In contrast, crosslinking was significantly
reduced in stationary phase PG in all four mutants (Fig. 4D),
although deletion of csiV resulted in less reduction than did
deletion of mrcA. These results, consistent with our analysis of PG
content, suggest that while PBP1A is largely dispensable in
exponential phase, it is linked to a significant fraction of PG
crosslinking in stationary phase, and that CsiV may promote (but
not be required for) PBP1A’s TP activity.
Unexpectedly, the average PG chain length (number of GlcNac-
MurNac subunits/chain) differed markedly between mutants and
growth phases (Fig. 4E,F). While all four mutants had slightly
longer PG chains (though this difference was only significant for
the mrcAS481T mutant) than the wild type in exponential phase
(Fig. 4E), the DlpoA and S481T mutants had significantly longer
Figure 5. Deletion of csiV is synthetically lethal with deletion of mrcB but not lpoB. (A) Growth curves, based on OD600, for the indicated V.
cholerae strains grown in LB. Data represent averages of technical triplicates and are representative of two experiments with similar results. (B) Cells in
which PBP1B’s native promoter was replaced by an arabinose-inducible promoter (PARA) were initially grown in the presence of arabinose (Ara
+), then
grown for 1 h in fresh medium without arabinose (Ara
2).
doi:10.1371/journal.pgen.1004433.g005
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chain length of DcsiV and DmrcA did not differ from the wild
type. The similarity between the DlpoA and mrcAS481T strain in
this assay suggests that LpoA may be particularly important for
augmenting PBP1A’s TP activity (as has also been observed in E.
coli) during the transition into or in stationary phase. However,
our results also suggest a possible interplay between PBP1A’s two
enzymatic activities, such that disruption of its TP activity may
cause deregulation of its TG activity. Additionally, it is noteworthy
that in our analyses of PG, unlike previously described assays, the
absence of the putative non-enzymatic factors (LpoA and CsiV)
does not always have the same consequences as the absence of
PBP1A.
CsiV shares genetic interactions with PBP1A and LpoA
In previous work, we have shown that mutations in V.
cholerae mrcA and lpoA are synthetically lethal with muta-
tions in mrcB and lpoB [18], i.e., that the PBP1B pathway is
essential in the absence of either PBP1A or LpoA. Similarly,
we were unable to generate an in-frame deletion of mrcB in
the DcsiV background, strongly suggesting that PBP1B is also
essential in this mutant, possibly because PBP1A activity in a
Figure 6. V. cholerae PBP1A is partially functional in the absence of CsiV. (A) Morphological changes of V. cholerae strains grown in the
presence of the PBP1B inhibitor cefsulodin. Frames are 5 min apart. (B) Growth (OD600) of DcsiV, DmrcA and DlpoA strains ectopically expressing
mrcA or mrcB and cultured in the presence of cefsulodin. Data are averages of three experiments, error bars represent standard deviation.
doi:10.1371/journal.pgen.1004433.g006
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Unexpectedly, we were able to generate a DcsiV DlpoB
mutant, although this strain did have a modest growth
deficiency (e.g., a longer lag phase) (Fig. 5A). Presumably,
either PBP1A or PBP1B (or perhaps both) has reduced activity,
rather than a total loss of function, in this double mutant. This
possibility is explored further below.
By placing mrcB under the control of an arabinose-inducible
promoter in the wt, DmrcA, DlpoA and DcsiV backgrounds,
we were able to observe the consequences of PBP1B depletion
in various genetic backgrounds. When grown in the presence
of arabinose, the majority of cells displayed normal cell
morphology in all 4 strains (Fig. 5B, S4 and not shown).
However, when arabinose was removed (resulting in PBP1B
depletion), almost all of the DmrcA, DlpoA and DcsiV cells
became spherical, as observed following exposure of these
strains to DAA. In contrast, PBP1B depletion had no effect on
the morphology of otherwise wt cells (data not shown). The
similarity between changes in the mutants’ cell shape in
response to DAA and to the absence of PBP1B suggests that a
key effect of DAA in V. cholerae may be to inhibit PBP1B.
PBP1A function is not entirely dependent upon CsiV
We also explored the requirement for CsiV, LpoA, and PBP1A
in PBP1B-deficient cells by treating the panel of mutant strains
with cefsulodin, which specifically inhibits PBP1B in V. cholerae
Figure 7. The absence of the endopeptidase ShyA enables PBP1B-independent growth of CsiV-deficient V. cholerae. (A) Growth
curves, based on OD600, for cultures containing the PBP1B inhibitor cefsulodin. Data are averages of technical quadruplicates and representative of 4
experiments with similar results, error bars represent standard deviation (B) Single-cell dynamics of DcsiV and the DcsiV DshyA double mutant in the
presence of cefsulodin. Cells were grown to OD600,0.3 and then applied to agarose pads containing 100 mg/ml cefsulodin. Arrowheads point to
blebs (C) DcsiV DshyA or DlpoA DshyA cells in which PBP1B’s native promoter was replaced with an arabinose-inducible promoter (PARA) were treated
as described in Fig. 5B.
doi:10.1371/journal.pgen.1004433.g007
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strains failed to grow in 100 mg/ml cefulodin, and instead adopted
a spherical morphology (Fig. 6A), as seen in response to PBP1B
depletion. However, when PBP1A was overproduced, CsiV-
deficient cells were able to grow in the presence of cefsulodin
(albeit not as well as when CsiV was exogenously produced)
(Fig. 6B), providing further evidence that PBP1A is not fully
inactive in the absence of CsiV. Alternatively, the observed
phenotype could indicate the rise of a resistant mutant or
degradation of the antibiotic under these conditions; however,
these alternative explanations seem unlikely since we never
observed growth in the control (DcsiV carrying empty
plasmid+cefsulodin). In contrast to DcsiV, neither overexpres-
sion of PBP1A nor of CsiV (data not shown) enabled LpoA-
deficient cells to grow in the presence of the antibiotic,
indicating that, as in E. coli, LpoA is absolutely required for
PBP1A function.
Mutation of an elongation-specific D,D-endopeptidase
prevents sphere formation in the DcsiV mutant
To gain additional insight into the cellular role of CsiV,
including its relationship to PBP1A and LpoA, we screened
transposon insertion libraries generated in the DcsiV, DmrcA, and
DlpoA strains for mutants that had regained the ability to replicate
in the presence of DAA. No suppressor mutations were obtained
for the DmrcA and DlpoA mutations; however, multiple
independent insertions within shyA (vca0079) were found to
enable growth of the DcsiV mutant in the presence of DAA. The
product of shyA, which is one of two functionally redundant
periplasmic hydrolases required for cell elongation in V. cholerae
Figure 8. CsiV interacts with LpoA. (A) Lysates from a csiV::csiV-his lpoA::lpoA-mCherry strain and a DlpoA::lpoA-mCherry strain were affinity
purified on NiNTA resin, then Western blotted with anti His and anti-mCherry antibodies to show copurification of CsiV and LpoA. (B) Purified MalE-
His (10 mM) and either LpoA-His77-653 (2.5 mM) or PBP1A-His (2.5 mM) were mixed with CsiV-His31-266 covalently attached to NHS-activated sepharose.
Protein associations were assessed via western blotting (anti-His) of Input (IN), flowthrough (F), third wash (W3), and eluate from boiled beads (E). (C)
Bacterial two-hybrid analysis of CsiV-LpoA and CsiV-PBP1A interactions. All constructs are truncated downstream of their signal sequences to allow
for cytoplasmic BACTH.
doi:10.1371/journal.pgen.1004433.g008
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PG. Subsequent analyses revealed that an in-frame deletion in
shyA was also necessary and sufficient to significantly mitigate the
growth and morphology defects of the DcsiV strain in the
presence of DAA (not shown) and cefsulodin (Fig. 7 A,B, S5)
and in response to PBP1B depletion (Fig. 7C), while deletion of
shyA did not enable growth or maintenance of normal cell shape
for PBP1A or LpoA-deficient strains under these conditions
(Fig. 7A,C). A likely explanation for these data is that a small
amount of PBP1A activity is still preserved in the DcsiV mutant
(but not the DmrcA or DlpoA strains), and that deletion of shyA
reduces PG cleavage and thereby lessens the need for PG
synthesis to a level that can be met by residual PBP1A activity.
However, it is also possible that CsiV does not modulate PBP1A
activity at all, but instead restrains the activity of ShyA, i.e., that
the PG-related phenotypes of the DcsiV strain are the
consequences of elevated PG degradation rather than reduced
synthesis. In theory, CsiV might modulate both synthetic and
degradative processes.
To explore whether ShyA deregulation in the absence of CsiV
might account for some of the phenotypes of the DcsiV mutant, we
assessed the effect of ShyA overexpression in the DcsiV, DmrcA,
and DlpoA strains. Notably, ectopic expression of ShyA, which we
have previously shown to be functional [16], had no effect on the
growth rate of the 3 mutants or of wt cells (Fig. S6), and all 4
strains maintained V. cholerae’s normal rod morphology (not
shown). Thus, although ShyA activity is likely to be highly
regulated in vivo ([16]), to date we lack evidence that its activity is
restrained by CsiV or components of the PBP1A pathway.
CsiV interacts with LpoA
Analyses of CsiV interaction partners also suggests that CsiV
probably modulates V. cholerae cell shape and growth predom-
inantly via an effect on PG synthesis rather than degradation. We
performed affinity purification analyses, using His-antibody resin
and 66 His-tagged CsiV expressed from its native chromosomal
location, to identify proteins that interact with CsiV (Fig. S7A).
To stabilize protein complexes, some cells were treated with the
crosslinker DSP (dithiobis succinimidyl propionate, Lomant’s
reagent) prior to lysis. Silver staining of column-purified proteins,
followed by mass spectrometry analysis of bands of interest,
revealed that LpoA copurified with CsiV even in the absence of
crosslinker. Purification of an additional protein complex, which
contained both LpoA and VC2168, a small, predicted periplasmic
protein of unknown function, was found to depend on crosslinking.
Most additional protein bands were found to contain chaperones,
ribosomal proteins, or CsiV. Comparable analyses, using lysates
from +/2 DSP-treated cells expressing LpoA-His6, confirmed the
crosslinker-independent co-purification of LpoA and CsiV and the
crosslinker-dependent co-purification of LpoA and VC2168 (Fig.
S7B). Given the stringency of washing conditions used (500 mM
NaCl), our data suggest that a high affinity interaction occurs
between LpoA and CsiV, consistent with CsiV modulating
PBP1A-mediated PG synthesis. The additional interaction part-
ner, VC2168, has a high degree of phylogenetic co-occurrence
with CsiV (string database, Fig. S2), suggesting it may likewise
play a role in cell envelope biogenesis. However, we have yet to
identify any changes in cell growth or morphology associated with
deletion of vc2168, and its cellular role remains obscure.
Somewhat unexpectedly, our mass spectrometry-based analyses
did not detect any interaction between PBP1A and either CsiV or
LpoA.
The interaction between CsiV and LpoA, but not PBP1A was
evident in a variety of additional assays as well. Western blotting of
affinity-purified proteins expressed from chromosomal loci con-
firmed that purification of LpoA was mediated by an interaction
with CsiV-His6 (Fig. 8A). Furthermore, when His6-tagged
purified LpoA61-433 or PBP1A (as well as a control protein, MalE)
were loaded on a column containing truncated CsiV (CsiV31-266)
covalently linked to NHS-activated Sepharose, only LpoA was
retained by the column (Fig. 8B). Finally, using a split adenylate
cyclase-based bacterial two-hybrid assay, CsiV was found to
interact with LpoA but not PBP1A (Fig. 8C) or ShyA (data not
shown). Thus, although all our interaction assays do not rule out
the possibility of interactions between CsiV and partners other
than LpoA, our observations provide strong support for the
hypothesis that CsiV modulates V. cholerae PG synthesis, and
thereby affects cell shape and growth, via directly interacting with
LpoA and promoting its function as an activator of PBP1A.
CsiV interacts with peptidoglycan
Since periplasmic enzymes involved in cell wall biosynthesis are
necessarily closely associated with the cell wall, we tested whether
Figure 9. CsiV interacts with peptidoglycan. Purified proteins
were incubated with SDS-extracted PG, then ultracentrifuged to pellet
PG and associated proteins. Proteins were visualized by anti-His
Western blot. For the lysozyme control, 1 mg/ml lysozyme was added
simultaneously with the addition of CsiV-His.
doi:10.1371/journal.pgen.1004433.g009
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purified CsiV with purified PG and then pelleted PG using
ultracentrifugation. CsiV exclusively associated with the pellet
fraction in the presence of PG, but not when lysozyme was added
to the reaction, suggesting a direct interaction between CsiV and
the cell wall (Fig. 9). Interestingly, purified LpoA did not interact
with PG by itself but was tethered to it by the simultaneous
presence of CsiV. This interaction did not appear to be required
for LpoA-PG interaction in vivo, as PG purified after treatment of
cells with DSP (which can mediate covalent attachment of proteins
to the cell wall as well as crosslinking of protein complexes [22])
retained natively expressed LpoA-His even in the absence of
PBP1A and CsiV (Fig. S8).
Discussion
Here, we discovered CsiV, a new player in cell wall biogenesis
in V. cholerae and presumably in all vibrios as well as the other
genera where strong homologues of this novel peptidoglycan-
binding protein are found. CsiV plays a critical role in PBP1A-
mediated cell wall biogenesis in V. cholerae and was identified by
screening a mapped transposon library for mutants whose growth
was inhibited by D-amino acids (DAA). The screen was inspired
by our work that revealed that D-amino acids are key modulators
of cell wall synthesis, particularly as cells enter stationary phase
[19]. D-amino acids inhibit growth of strains lacking PBP1A or its
putative activator LpoA, and exposure of these mutants to DAA
leads to loss of rod shape and sphere formation through an
unknown mechanism [18]. CsiV-deficient cells, like PBP1A and
LpoA-deficient cells, turn spherical in stationary phase, in the
presence of DAA, and upon depletion of PBP1B. Additionally, V.
cholerae lacking CsiV, LpoA, or PBP1A are hypersensitive to the
bile acid deoxycholate and to cefsulodin, which inhibits V.
cholerae PBP1B, and they all show marked changes in PG content
in stationary phase. CsiV, LpoA and PBP1A are also all required
for survival of V. cholerae lacking PBP1B, although the
requirement for CsiV is diminished in the absence of the
endopeptidase ShyA. CsiV interacts with LpoA as well as with
PG, but does not appear to bind to PBP1A. Collectively, our data
suggest that CsiV acts through LpoA (and thereby through
PBP1A) to promote PG synthesis in V. cholerae, and that V.
cholerae PBP1A is largely inactive in the absence of CsiV.
Despite the extensive similarities of the phenotypes of V.
cholerae csiV, lpoA, and mrcA mutants, there are also notable
differences among these strains. A key difference is that
overexpression of mrcA enables growth of the csiV mutant, but
not the lpoA mutant, in the presence of cefsulodin. In the presence
of this antibiotic, PBP1A-mediated PG synthesis is essential for
growth; consequently, our results suggest that PBP1A retains a
small amount of activity in the absence of csiV, but is completely
inactive when LpoA is not present. Since CsiV interacts with
LpoA, but does not appear to interact with PBP1A, a likely
explanation for these results is that CsiV markedly enhances the
ability of LpoA to activate PBP1A. Western blot analyses of the
abundance of epitope tagged LpoA in the presence and absence of
CsiV (Fig. S8 and data not shown) suggest that CsiV is not
required simply to stabilize LpoA levels, nor is CsiV required to
tether LpoA to PG (Fig. S8). Our path to elucidating the precise
means by which CsiV modulates LpoA’s activity will become
clearer as the molecular bases for LpoA’s enhancement of PBP1A
activity are illuminated.
In related analyses, we observed that disruption of V. cholerae
lpoB is also possible in a csiV mutant, but not in an lpoA or mrcA
mutant, and that disruption of mrcB is not possible in any of the
three mutants. The former results are consistent with our previous
conjecture that only the csiV mutant has residual PBP1A activity.
Additionally, the differential requirement for lpoB and mrcB in
the csiV mutant suggests that PBP1B may likewise have a small
amount of residual activity in the absence of LpoB, and that
PBP1B-mediated PG synthesis is critical for survival of the csiV
lpoB mutant. Consistent with this supposition, we have found that
growth of this strain is blocked by the PBP1B-specific antibiotic
cefsulodin (data not shown).
Our studies have also revealed extensive similarities between the
consequences of PBP1B depletion, exposure to cefsulodin, and
exposure to DAA. All inhibit growth of PBP1A, LpoA, and CsiV-
deficient cells and induce loss of rod shape and adoption of a
spherical morphology. Although they do not provide conclusive
evidence, these results suggest that one effect of DAA is to inhibit
PBP1B activity. DAA might bind directly to PBP1B; alternatively,
PG in which non-canonical DAA have been incorporated might
be a poor substrate for crosslinking by PBP1B. Regardless, if
effective reduction of PBP1B activity in the presence of DAA
occurs, then PBP1A likely accounts for the majority of PG
synthesis in stationary phase cultures, which accumulate high
levels of DAA. Such a role for PBP1A would explain why the
survival and PG content of PBP1A pathway mutants is particularly
reduced during stationary phase.
Since the detrimental effects of csiV deletion in the absence of
PBP1B activity were mitigated by inactivation of the endopepti-
dase ShyA, it is formally possible that CsiV acts as a negative
regulator of PG degradation rather than an indirect activator of
PG synthesis. However, this scenario seems unlikely to account for
all of CsiV’s activity for a variety of reasons. First, CsiV interacted
with LpoA, while we did not detect an interaction between CsiV
and ShyA or any other endopeptidase. Second, overexpression of
ShyA did not impede V. cholerae growth, even in the absence of
CsiV, suggesting that restraint of detrimental PG digestion is not
dependent upon CsiV (Fig. S6). Additionally, the deletion of shyA
promoted but did not completely restore growth of the DcsiV
mutant in cefsulodin, so, at minimum, the role of CsiV cannot be
limited to regulation of ShyA activity. Thus, CsiV’s most probable
role is in promoting PG synthesis, via enhancing LpoA’s activation
of PBP1A.
Finally, our observations have bearing on a central question in
cell wall biogenesis - whether PG synthesis and degradation are co-
ordinately regulated. These key processes may be tightly coupled,
so that one ‘‘degradation unit’’ is always associated with one
‘‘synthesis unit’’ of cell wall material. It is also possible that
degradation and synthesis are independently regulated in response
to one or more cellular stimuli. For example, degradation might
occur in response to elevated turgor pressure in the cell, while
synthesis might be stimulated by detection of gaps within the PG
structure. In either case, our observations suggest that cell survival
depends on proper maintenance of a balance between these two
processes. When CsiV and PBP1B are both absent, and
consequently PG synthesis rests solely on residual PBP1A activity,
cell growth is dependent upon compensatory measures: either
removal of the endopeptidase ShyA or overexpression of PBP1A,
which should reduce PG degradation or increase synthesis,
respectively. In contrast, cell growth is not markedly impaired
when only a single bifunctional PBP (PBP1A or PBP1B) was
absent. While speculative, our findings are therefore consistent
with a scenario in which PG synthesis and degradation are
buffered, rather than precisely calibrated, processes, i.e. that
overall PG synthetic activity can be lowered substantially until a
threshold is reached, below which degradation outweighs synthesis
to a degree that makes it impossible to maintain rod-shape. This is
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transpeptidase essential for cell elongation, in E. coli [23].
Materials and Methods
Media and growth conditions
All strains were routinely grown at 37uC in LB medium
supplemented with 200 mg/ml streptomycin. For growth curves,
overnight cultures were diluted 1:100 into fresh medium and
incubated shaking until OD600,0.1–0.3. Cultures were then
normalized to an OD600 of exactly 0.1 and transferred to 200 mL
volume in 200-well honeycomb plates. Growth curves were then
conducted at 37uC with continuous shaking in a Biotek growth
curve machine.
Plasmid construction
Primers are summarized in Table S1.
Complementation plasmids were constructed by cloning PCR
fragments amplified with primers TDP166/167 (csiV), TDP168/
169 (mrcA) or TDP172/173 (lpoA) digested with Xma1/BamH1
(NEB) into likewise digested and Calf intestinal phosphatase
(CIP,NEB)-treated pHL100.
pHL100shyA was constructed using isothermal assembly [24] of
the product of primers TDP529/530 with Sma1 (NEB)-digested
and CIP-treated pHL100.
pHL100csiV-mCherry was constructed using isothermal assem-
bly of Sma1-digested/CIP-treated pHL100 and the products of
TPD310/311 and TDP238/239.
All deletion plasmids are derivatives of the suicide-vector
pCVD442 [25]. 300–500 bp long upstream and downstream
homologies were amplified using primers TDP138/139+
TDP140/141 (lpoA), TDP205/206+TDP207/208 (mrcA)o r
TDP282/283+TDP284/285 (lpoB), purified (Qiagen PCR puri-
fication kit) and fused using SOE PCR with the respective outside
primers (in bold). The resulting product was digested with Xba1
(NEB) and ligated into likewise digested pCVD442.
The csiV deletion plasmid was constructed using isothermal
assembly of the products of TDP360/361+TDP362/362 into
Sma1-digested pCVD442.
Overexpression plasmids for protein purification are derivatives
of pET28b. Open reading frames encoding truncated CsiV and
LpoA were cloned into the Nco1/Xho1 sites using the PCR
products of TDP110/111 and TDP201/88. HisPBP1A was
amplified using primers TDP535/536 and cloned into Nco1-
digested pET28b using isothermal assembly.
Site-directed mutagenesis
Site-directed mutagenesis was performed using the QuikChange
kit (Agilent) following the manufacturer’s recommendations.
Primers TDP160/161 were used to amplify mutated mrcA from
pHL100mrcA. Mutated mrcA was then amplified using primers
TDP212/214 and used as template together with the products of
TDP196/212+213/199 in a SOE PCR reaction with primers
TDP196/199. The resulting product, containing mutated mrcA+
upstream and downstream homology regions was then digested
with Xba1 and ligated into likewise digested pCVD442.
Strain construction
Strains and plasmids are summarized in Table S2. All Vibrio
cholerae strains are derivatives of El Tor N16961.
Deletion and replacement mutants were generated using the
suicide plasmid pCVD442 or the lacZ integration plasmid pJL1
[26] in the donor strain SM10 using published methodology ([25]).
Transposon screen
An ordered transposon library in 96 well format [27] was
transferred to 200 mL LB medium using a 96-Pin Tool, incubated
overnight at 37uC and then spotted on LB agar plates with either
no addition or 5 mM D-methionine (Sigma). After another
overnight incubation, agar plates were visually inspected for
growth. Colonies that grew neither on LB nor on D-Met were
recultured from the library and retested for growth on D-Met
individually. Colonies that grew on LB agar but not on LB were
scored as hits.
PG isolation and HPLC analysis
To isolate murein sacculi, either 1L (stationary phase culture,
OD600,2) or 2L (exponential phase culture, OD600,0.2) of
culture was pelleted, resuspended in 5 ml PBS and slowly added to
10 ml of boiling 10% SDS while stirring. Samples were boiled for
4 h, then stirred overnight at 37uC. Cell wall material was then
pelleted by ultracentrifugation (110.000 rpm, 1 h) and washed 36
in MQ water.
Peptidoglycan (PG) samples were analyzed as described
previously [28]. After washing with MQ water, samples were
digested with pronase E (100 mg/ml) in a TrisHCl 10 mM pH 7.5
buffer for 1 hour at 60uC to remove Braun’s lipoprotein. After
heat-inactivation and washing, the samples were treated with
muramidase (100 mg/ml) for 16 hours at 37uC, in 50 mM
phosphate buffer, pH 4.9. Muramidase digestion was stopped by
boiling, coagulated proteins were removed by centrifugation
(10 min, 14000 rpm) and the supernatants were reduced with
150 ml 0.5 M sodium borate pH 9.5 and sodium borohydride
(10 mg/ml final concentration, 30 min at RT). Finally, samples
(100 ml) were adjusted to pH 3.5 with phosphoric acid.
UPLC analyses of muropeptides were performed on an
ACQUITY UPLC BEH C18 Column, 130A ˚, 1.7 mm,
2.1 mm6150 mm (Water, USA) and detected at Abs. 204 nm.
Muropeptides were separated using a linear gradient from buffer
A (phosphate buffer 50 mM pH 4.35) to buffer B (phosphate
buffer 50 mM pH 4.95 methanol 15% (v/v)) in a 20 minutes run.
Quantification of relative abundances of muropeptides
Identity of the peaks was assigned by comparison of the
retention times and profiles to other chromatograms in which mass
spectrometry data has been collected. The relative amount of each
muropeptide was calculated by comparison of the relative area of
the peak compared to the total area of the chromatogram.
Representative chromatograms are shown in Fig. S9.
The degree of crosslinking is expressed as the relative amount of
peptide bonds that connect two peptide stems ([dimers+trimers/
2]). The average length is indirectly proportional to the relative
amount of anhydro-muropeptides.
PG quantifcation
Isolated PG sacculi were hydrolysed for 15 hours with HCl 6M
at 100uC, followed by water removal using a centrifugal
concentrator (Speed Vac). Completely dried samples were
resuspended in water and treated with ninhydrin (250 mg of
ninhydrin in 4 ml of phosphoric acid 0.6 M and 6 ml of pure
acetic acid) for 5 minutes at 100uC. Absorbance was measured at
434 nm and concentration of muropeptides was calculated by
comparison to a mDAP standard curve [29].
Protein purification
All proteins were overproduced in E. coli strain RosettaGami
(Invitrogen) as 66His-tagged constructs from a pET28b+ vector.
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truncated CsiV31-266-His, truncated LpoA61-653 or full-length
His-PBP1A were diluted into 1 L LB broth, grown until
OD600=0.5. Flasks were then cooled down at 4uC for 30 min,
followed by addition of 1 mM IPTG and slow shaking at room
temperature for 16 h. Cells were pelleted, washed 16 in PBS
and resuspended in Buffer A (20 mM Tris, pH 7.2, 150 mM
NaCl, 1 mM DTT+protease inhibitor cocktail (Roche) and
stored at 280uC. Following thawing on ice, cells were
disrupted by passaging through a French press twice. Salt
was then adjusted to 300 mM NaCl and 0.1% triton x-100
(reduced, Sigma) as well as 1% CHAPS (Sigma) and 40 mM
Imidazole added. Lysates were then incubated for 1 hour
rotating at 4uC, followed by centrifugation for 1 h
(25.000 rpm, Beckman Coulter Avanti J26-XP centrifuge, JL-
25.50 rotor) at 4uC. Nickel NTA resin (0.5 ml, equilibrated in
buffer A) was then added to the supernatant, followed by
incubation at 4uC, rotating. The lysate was then allowed to
d r a i nf r o mt h eN i - r e s i nb yf l o w - t h r o u g hi naf i l t e rc a r t r i d g e
and the resin washed (5610 ml) with Wash buffer (Buffer A
adjusted to 500 mM NaCl, 50 mM imidazole and 0.1%
triton x-100) and eluted with wash buffer containing an
imidazole gradient (60–300 mM). Fractions were subjected to
SDS PAGE and Coomassie Brilliant Blue staining and the
cleanest fractions pooled. Proteins were quantified using
Nanodrop.
Co-affinity purification
For co-affinity purification, strains carrying chromosomal C-
terminal His fusions of the proteins of interest were grown to
OD600,0.5 in LB, pelleted, washed twice in PBS and then
resuspended in PBS and crosslinked for 30 min with 5 mM
DSP (Thermo Scientific). The pellet was then washed 36 in
PBS and resuspended in buffer B (20 mM Tris, 300 mM NaCl,
1 mM DTT, 1% Triton X-100, Roche complete protease
inhibitor) and cells were lysed by passaging three times through
a French Press. Then, 1% CHAPS was added and the lysates
s t i r r e d2h–o v e r n i g h ta t4 uC. Lysates were then cleared by
centrifugation (25.000 rpm, 1 h) and incubated for 2 h with
His-antibody resin (R&D systems) equilibrated in buffer B. The
resin was washed 36with Buffer B adjusted to 500 mM NaCl
and protein complexes eluted with Buffer C (100 mM glycine,
pH 2.5, 300 mM NaCl, 1 mM DTT, 1% Triton X-100).
Proteins were then concentrated ,10fold using Amicon
centrifuge filter units with 10 kDa MW cutoff and subjected
to SDS PAGE followed by silver staining. Bands of interest
were cut out from the gel and proteins identified via Mass
Spectrometry.
Targeted protein-protein interaction assays
CsiV-his was covalently linked to NHS-activated sepharose
resin (Thermo Scientific) using the manufacturer’s protocol.
Purified LpoA-his and His-PBP1A were added to CsiV-Sephar-
ose equilibrated in 20 mM Tris-HCl (pH 7.2), 150 mM NaCl,
1 mM DTT and 0.1% reduced Triton X-100 and incubated at
4uC rotating for 2 h. The resin was then washed 36with buffer
and proteins eluted by boiling the resin in buffer containing 1%
SDS (95uC, 5 min). Proteins were then visualized via Western
Blot.
Bacterial Two Hybrid Analysis (BACTH)
BACTH was conducted using a split adenylate cyclase system as
described previously [30].
PG binding assay
PG binding was assayed as described previously [31]. In short,
purified PG sacculi were incubated with purified proteins in
pulldown buffer (20 mM Tris/maleate pH 6.8, 50 mM NaCl,
10 mM MgCl2 0.1% Triton X-100) for 30 min on ice, then
ultracentrifuged (110.000 rpm). Pellets were washed once in
pulldown buffer and proteins in pellets and supernatant fractions
visualized by Western Blot.
Supporting Information
Figure S1 Western blot of csiV-mCherry. Ectopic expression of
CsiV-mCherry was induced by addition of 200 mM IPTG for 2 h,
followed by lysis and western blotting using anti-mCherry
antibody. The two observed bands are consistent with the
predicted sizes of CsiV-mCherry +/2 signal sequence.
(TIFF)
Figure S2 Co-occurrence patterns of CsiV and VC2168. Data were
extracted from the String database (http://string-db.org/) and repre-
sent the subset of phyla that contain either CsiV, VC2168 or both.
(TIFF)
Figure S3 Comparison of intestinal colonization in infant mice
by wt, csiV and mrcA V. cholerae. Strains were orally inoculated
into suckling mice. Total cfu/mouse in intestinal homogenates was
assessed after 24 h.
(TIFF)
Figure S4 Effectof PBP1Bdepletion on the morphologyof DcsiV
cells. Cells in which PBP1B’s native promoter was replaced by an
arabinose-inducible promoter (PARA) were initially grown in the
presence of arabinose (ARA+), then resuspended in fresh medium
without arabinose (ARA2) and imaged at 1 minute intervals.
(TIFF)
Figure S5 Influence of ShyA expression on the growth of a
cefsulodin treated DcsiV DshyA mutant. Growth curves, based on
OD600, for a DcsiV DshyA derivative which carries a chromo-
somal shyA under IPTG control inserted into a neutral locus
(lacZ) grown in the presence of 100 mg/ml cefsulodin, IPTG
(200 mM), both, or neither. Data are averages of two biological
replicates; error bars represent standard deviation.
(TIFF)
Figure S6 ShyA overproduction in DcsiV is not toxic.
Exponentially growing, uninduced cells carrying an inducible
shyA expression construct (pshyA) were diluted into fresh medium
+/2 500 mM IPTG at 37uC. A representative experiment (of two
repetitions with similar results) is shown; data are averages of
technical quadruplicates.
(TIFF)
Figure S7 CsiV and LpoA are copurified from V. cholerae cell
lysates. (A) Lysates of csiV::csiV-his6 cells +/2 Dithiobis
succinmidyl propionate (DSP) treatment were affinity purified on
His-antibody resin. Purified proteins were visualized via silver
staining of SDS-PAGE gels, and protein bands of interest were
analyzed by mass spectroscopy. (B) Lysates of wt and lpoA::lpoA-
his6 cells +/2 DSP treatment were affinity purified on His-
antibody resin. Purified proteins were identified as in (A).
(TIFF)
Figure S8 The association of LpoA with PG in vivo is
independent of CsiV and PBP1A. Soluble (S) and PG-associated
(P) proteins were isolated from an lpoA::lpoA-his6 strain and
derivatives lacking csiV, mrcA, or both after DSP crosslinking.
Following reversal of crosslinks, the presence of LpoA-His6 in each
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antibody.
(TIFF)
Figure S9 UPLC chromatograms. Representative chromato-
grams of muramidase-digested PG samples.
(TIF)
Table S1 Oligos used in this study.
(XLS)
Table S2 Strains and plasmids.
(XLS)
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